Language:
Daily summary of financings for therapeutic biotechnology company executives and investors
Thursday, May 1, 2025
Wednesday, April 30, 2025
Novartis’s $800 Million Acquisition of Regulus
Tuesday, April 29, 2025
Friday, April 25, 2025
Verastem’s $75 Million Private Placement
Coeptis’s Merger with Z Squared
Thursday, April 24, 2025
Granite’s $100 Million Series A
Overture’s $57 Million Venture Financing
Grove’s $30 Million Series ACytovation’s $6 Million Fund Raise
Tuesday, April 22, 2025
Biolinq’s $100 Million Series C
GenrAb $6 Million Private Placement
Sirona’s $2 Million Private Placement
Monday, April 21, 2025
Aptevo’s $2 Million Registered Direct Offering
Thursday, April 17, 2025
Sernova’s $4 Million Debt Financing
Wednesday, April 16, 2025
Sponsors
In coordination with an executive placement firm that is independent and unaffiliated with Collabrity, Inc., we may coordinate with executive(s) who are sourced by that firm and also independent and unaffiliated with Collabrity, Inc.: “Collabrity Executive(s)” does not imply an employment or independent contractor relationship with Collabrity, Inc.
Securities offered through Finalis Securities LLC Member FINRA / SIPC. Collabrity Inc. is not a registered broker-dealer, and Finalis Securities LLC and Collabrity Inc. are separate, unaffiliated entities. Finalis Privacy Policy | Finalis Business Continuity Plan | FINRA BrokerCheck